Reversal of anticoagulation without protamine using a heparin removal device after cardiopulmonary bypass

Medicine & Life Sciences

• Device Removal 84%
• Protamines 75%
• Cardiopulmonary Bypass 59%
• Heparin 54%
• Swine 11%
• Membrane Oxygenators 7%
• Clinical Trials, Phase I 6%
• Sepharose 5%
• Hypothermia 5%
• Heart Atria 4%
• Biomedical Research 4%
• Hematocrit 4%
• Lysine 4%
• Leukocyte Count 4%
• Platelet Count 4%
• Catheters 3%
• Hemodynamics 3%
• Ligands 3%

Engineering & Materials Science

• Heparin 100%
• Plasmas 9%
• Oxygenators 8%
• Hypothermia 7%
• Ligands 6%
• Platelets 6%
• Catheters 6%
• Hemodynamics 5%
• Sorption 5%
• Sulfates 5%
• Blood 4%
• Membranes 4%
• Pumps 3%
• Substrates 3%
• Fibers 3%

Chemical Compounds

• Heparin 61%
• Hemodynamic 7%
• Hematocrit 6%
• Plasma 6%
• Antihypertensive 5%
• Time 5%
• Agarose 5%
• Pump 4%
• Sulfate 3%
• Sorption 3%
• Fiber 3%
• Ligand 2%